Featured Research

from universities, journals, and other organizations

Human-specific evolution in battling bugs and building babies

Date:
November 5, 2010
Source:
Public Library of Science
Summary:
Researchers have described qualitative killer cell immunoglobulin-like receptor differences, acquired after humans and chimpanzees separated 6 million years ago and mainly a consequence of innovation in the human line. These differences open up an exciting avenue for explaining the differential susceptibility of humans and chimpanzees to devastating infectious diseases such as HIV/AIDS and malaria.

Although human and chimpanzee immune systems have many identical components, this is not the case for the family of killer cell immunoglobulin-like receptors (KIR) controlling white blood cells known as natural killer (NK) cells. Published in the open-access journal PloS Genetics on November 4, a paper by Stanford University researchers describes qualitative KIR differences, acquired after humans and chimpanzees separated 6 million years ago and mainly a consequence of innovation in the human line.

These differences open up an exciting avenue for explaining the differential susceptibility of humans and chimpanzees to devastating infectious diseases such as HIV/AIDS and malaria.

While immunological research has increasingly concentrated on the inbred laboratory mouse for the last half century, mice actually represent a poor model for human KIR because their NK cell receptors are so disparate from the simian primate counterparts. As a result, the researchers looked at chimpanzee KIR so that they could accurately compare them with the well-characterized human versions.

NK cells serve in both immune defense and reproduction; they contribute to early defense against infection and are implicated during the early phase of pregnancy, when uterine NK cells orchestrate enlargement of maternal arteries that will supply blood to the placenta and nourish the fetus. These vital NK cell functions seem subject to variable and competing selective pressures that have driven rapid KIR evolution and produced striking differences between humans and chimpanzees, as closely related as they are. These distinctions derive from adaptations in the human line in response to selective pressures on human NK cells due to the competing needs of defense and reproduction. Whereas chimpanzees have a potent battery of KIR that appears aimed at fighting infection, the human KIR represent a functional compromise between battling bugs and building babies.

This study was supported by National Institutes of Health grants AI24258 and AI22039 to Peter Parham; the authors also acknowledge the support of the Yerkes Center Base Grant RR000165.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Abi-Rached L, Moesta AK, Rajalingam R, Guethlein LA, Parham P. Human-Specific Evolution and Adaptation Led to Major Qualitative Differences in the Variable Receptors of Human and Chimpanzee Natural Killer Cells.. PLoS Genet, 6(11): e1001192 DOI: 10.1371/journal.pgen.1001192

Cite This Page:

Public Library of Science. "Human-specific evolution in battling bugs and building babies." ScienceDaily. ScienceDaily, 5 November 2010. <www.sciencedaily.com/releases/2010/11/101104171334.htm>.
Public Library of Science. (2010, November 5). Human-specific evolution in battling bugs and building babies. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/11/101104171334.htm
Public Library of Science. "Human-specific evolution in battling bugs and building babies." ScienceDaily. www.sciencedaily.com/releases/2010/11/101104171334.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins